- European Monitoring Centre for Drugs and Drug Addiction. New trends in synthetic drugs in the European Union: epidemiology and demand reduction responses. EMCDDA Insights series 1. Luxembourg: Office for Official Publications of the European Communities, 1997.
- World Health Organization (WHO). Amphetaminetype stimulants: report from the WHO meeting on amphetamines, MDMA and other psychostimulants, Geneva, 1996. Geneva: WHO Programme on Substance Abuse, 1997.
- UNDCP. Amphetamine-type stimulants: a global review (UNDCP Technical Series Number 3). Vienna: United Nations International Drug Control Programme, 1996.
- UNDCP. World drug report. New York: Oxford University Press, 1997.
- UNDCP. World drug report 2000. New York: Oxford University Press, 2000.
- Department of Health, Drug Misuse and Dependence. Guidance on clinical management. Norwich, UK: The Stationery Office, 1999.
- Ramsey M, Spiller J. Drug misuse declared in 1996: latest results from the British Crime Survey. London: Home Office, 1997.
- EMCDDA. Evaluating the treatment of drug abuse in the European Union. Luxembourg: Office for Official Publications of the European Communities, 1999.
- MacGregor S. Drugs in British society. London: Roudedge, 1989.
- Klee H, Wright S. Amphetamine use and treatment: a study of the impediments to effective service delivery. Part 1. Access to treatment services, Blue Book Series. The Manchester Metropolitan University, Manchester: SRHSA, 1999.
- Klee H. A new target for behavioural research-amphetamine misuse. Br J Addict 1992;87:439-46.
- Wright S, Klee H, Reid P. Attitudes of amphetamine users to treatment services. Drugs Educ Prev Policy 1999;6:71-86.
- Myles J. Treatment for amphetamine misuse in the United Kingdom. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. The Netherlands: Harwood Academic Publishers, 1997:69-80.
- Wright S, Klee H. Violent crime, aggression and amphetamine. Drugs Educ Prev Policy 2001;8: 73-90.
- Suwaki H, Fukui S, Konuma K. Methamphetamine abuse in Japan. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. The Netherlands: Harwood Academic Publishers, 1997:199-214.
- Klee H, Reid PAmphetamine misusing groups: a feasibility study of the use of peer group leaders for drug prevention work among their associates. Central Drug Prevention Unit (CDPU) Research Report 3. London: The Home Office, 1995.
- Klee H. The love of speed: an analysis of the enduring attraction of amphetamine sulphate for British youth. J Drug Issues (Special Edition) 1998;28:33-55.
- Department of Health. Task force to review services for drug misusers: report of an independent review of drug treatment services in England. London: Department of Health, 1996.
- Klee H, Wright S, Rothwell J. Amphetamine use and treatment: a study of individual and policy impediments to effective service delivery. Final Report to the Department of Health Task Force, 1997.
- Wright S, Klee H, Reid P. Interviewing illicit drug users: observations from the field. Addict Res 1998;6:517-35.
- Gossop M, Stewart D, Marsden J. NTORS at one year. The National Treatment Outcome Research Study: changes in substance use, health and criminal behaviours one year after intake. London: Department of Health, 1998.
- Strang J, Sheridan J. Prescribing amphetamines to drug misusers: data from the 1995 national survey of community pharmacies in England and Wales. Addiction 1997;92:833-8.
- Bradbeer TM, Fleming PM, Charlton P, Crichton JS. Survey of amphetamine prescribing in England and Wales. Drug Alcohol Rev 1998;17:299-304.
- Chamaud B, Griffiths V. Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend 1998;52:79-84.
- Pates R, Coombes N, Ford N. A pilot programme: prescribing dexamphetamine for amphetamine users. J Subst Misuse 1996;l:80-4.
- McBride AJ, Sullivan G, Blewett AE, Morgan S. Amphetamine prescribing as a harm reduction measure: a preliminary study. Addict Res 1997;5:95-112.
- Hendriks V. Evaluating drug-abuse treatment: current and future perspectives, In: Evaluating the treatment of drug abuse in the European Union, ch. 1. EMCDDA Scientific Monograph series no. 3. Luxembourg: EMCDDA, 1999.
- Klee H, Wright S. Amphetamine use and treatment: a study of the impediments to effective service delivery. Fart 2. Treatment and its outcomes, Blue Book Series. The Manchester Metropolitan University, Manchester: SRHSA, 1999.
- Klee H, Wright S, Morris J. Amphetamine users in treatment: actors associated with sustained abstinence from street drugs. Addict Res 1999;7:239-65.
- Wright S, Klee H. A profile of amphetamine users who present to treatment and do not return. Drugs Educ Prev Policy 1999;6:227-41.
- Klee, H, Jackson M. Illicit drug use, pregnancy and early motherhood. Blue Book Series. The Manchester Metropolitan University, Manchester: SRHSA, 1998.
- Tetlow VA, Merrill J. Rapid determination of amphetamine stereoisomer ratios in urine by gas chromatography-mass spectroscopy. Ann Clin Biochem 1996;33:50-4.
- Shearer J, Wodak A, Mattick RPet al. A randomised controlled trial of the feasibility of monitoring controlled prescribing of dexamphetamine. NDARC Technical Report no. 75. Sydney, Australia: National Drug and Alcohol Research Centre, 1999.
- Strauss A, Corbin J. Basics of qualitative research. Newbury Park, CA: Sage, 1990.
- White R. Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 2000;95:229-38.
- Mattick RF, Darke S. Drug replacement treatments: is amphetamine substitution a horse of a different colour? Drug Alcohol Rev 1995;14:389-94.
- Lintzeris N, Holgate F, Dunlop A. Addressing dependent amphetamine use: a place for prescription. Drug Alcohol Rev 1996;15:189-95.
- Kamieniecki G, Vincent N, Allsop S, Lintzeris N. Models of intervention and care or psychostimulant users. Monograph Series no. 32. Canberra, Australia: National Centre for Education and Training on Addiction, Commonwealth Department of Health and Family Services, 1998.
The role of substitute therapy in the treatment of problem amphetamine use
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.